Cardiac Biotech Solutions Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBSC research report →
Price Chart
About the company
Operating globally through its international subsidiaries, Cardiac Biotech Solutions Inc. delivers advanced products and services for non-invasive, mobile cardiac monitoring. The company's portfolio includes FDA and CE-approved EKG devices, sophisticated cloud-based data acquisition software, and intuitive smartphone applications compatible with both iOS and Android platforms.
- CEO
- Charles K. Martin
- IPO
- 2016
- Employees
- 4
- HQ
- Las Vegas, NV, US
Get TickerSpark's AI analysis on CBSC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.79M
- P/E
- -7.95
- PEG
- -0.08
- P/S
- 39.17
- P/B
- -2.62
- EV/EBITDA
- -5.40
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- -725.51%
- Net Margin
- -578.04%
- ROE
- 39.17%
- ROIC
- 94.18%
Latest fiscal year · YoY change
- Revenue
- $152.73K+268.9%
- Gross Profit
- $0-100.0%
- Op Income
- $-1,156,842
- Net Income
- $-895,973+46.7%
- EPS
- $-0.01+49.1%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.06
- 52W Low
- $0.02
- 50D MA
- $0.03
- 200D MA
- $0.04
- Beta
- 1.93
- RSI (14)
- 53
- Avg Volume
- 14.35K
No earnings-call transcripts are available for CBSC yet.
- Free Float
- 29.2%
- Shares Outstanding
- 165.44M
- Float Shares
- 48.29M
Our CBSC coverage
Recent articles, reports, and earnings notes.
No research on CBSC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBSC report →Contrasting ADMA Biologics (NASDAQ:ADMA) and Cardiac Biotech Solutions (OTCMKTS:CBSC)
defenseworld.net · Apr 5
Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT
prismmediawire.com · Sep 25
CBSC Announces $375,000 Purchase Order and Launch of Recurring Revenue Program with Noventis Medical
prismmediawire.com · Sep 11
Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
globenewswire.com · Sep 4
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
accessnewswire.com · May 8
CB Scientific Inc. (CBSC) Formally Launches Next Generation MyCardia AT Cardiac Monitor
accessnewswire.com · Feb 25
CB Scientific, Inc. Appoints Trip Thomas as Chief Financial Officer
accesswire.com · Oct 3
CB Scientific, Inc. Announces Voluntary Delisting from OTCQB Venture Market
accesswire.com · Aug 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.